Keywords: merck, kgaa, applies, extend, emea, indication, erbitux

Merck KGaA applies to extend EMEA indication for Erbitux

Article | 23 June 2008

Print This

German drug and chemicals firm Merck KGaA has submitted an application to the European Medicines Agency (EMEA) to broaden the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in